Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 4Unknown 2Terminated 1

Sponsor Class

OTHER 2FED 2

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Skin Neoplasms 1Prostate Cancer Prevention 1Multiple Endocrine Neoplasia Type 1 1Healthy Volunteers 1Dermatitis, Contact 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Gelatin × Clear all
NCT01265953 2019-05-01

PBroC

Portland VA Medical Center

Phase NA Completed
98 enrolled 10 charts
Genitourinary

Prostate Cancer Prevention

NCT01032343 2013-08-22

An Immunonutritional Approach to the Prevention of Skin Cancer

University of Manchester

Phase NA Completed
90 enrolled
Dermatologic

Dermatitis, Contact, Skin Neoplasms

NCT01526759 2012-03-12

FLiTS

Wageningen University

Phase NA Completed
35 enrolled
Endocrine

Multiple Endocrine Neoplasia Type 1

NCT01293617 2011-07-18

Blackberry Intake and Biomarkers of Cancer Risk

USDA Beltsville Human Nutrition Research Center

Phase NA Completed
52 enrolled

Healthy Volunteers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡